Meeker H C, Williams D L, Anderson D C, Gillis T P, Schuller-Levis G, Levis W R
Department of Neuroimmunology, New York State Institute for Basic Research in Developmental Disabilities, Staten Island 10314.
Infect Immun. 1989 Dec;57(12):3689-94. doi: 10.1128/iai.57.12.3689-3694.1989.
In order to study antibody reactivity to the Mycobacterium leprae 65-kilodalton (kDa) antigen, peptides representing overlapping sequences of the 65-kDa protein were synthesized, and a recombinant protein expression system for r65-kDa was constructed. Mouse monoclonal antibodies and leprosy patient seroreactivity to peptides and r65-kDa were tested by an enzyme-linked immunosorbent assay. All seven of the monoclonal antibodies used in this study reacted with their previously defined epitopes when tested against peptides. All monoclonal antibodies also reacted with r65-kDa. Leprosy patient seroreactivity to peptides and r65-kDa was seen in about one-third of active multibacillary cases. Specimens from patients positive for antibodies to peptides were seen to recognize different epitopes than did mouse monoclonal antibodies used in this study. It is concluded that substantial differences exist between mouse monoclonal antibodies and human leprosy patient reactivity to the 65-kDa antigen and that human seroreactivity to the 65-kDa antigen is indicative of a highly elevated bacillary load.
为了研究针对麻风分枝杆菌65千道尔顿(kDa)抗原的抗体反应性,合成了代表65-kDa蛋白重叠序列的肽段,并构建了r65-kDa的重组蛋白表达系统。通过酶联免疫吸附测定法检测了小鼠单克隆抗体以及麻风病患者对肽段和r65-kDa的血清反应性。在针对肽段进行检测时,本研究中使用的所有七种单克隆抗体均与其先前确定的表位发生反应。所有单克隆抗体也与r65-kDa发生反应。在约三分之一的活动性多菌型病例中观察到麻风病患者对肽段和r65-kDa的血清反应性。与本研究中使用的小鼠单克隆抗体相比,对肽段抗体呈阳性的患者样本识别出不同的表位。得出的结论是,小鼠单克隆抗体与人类麻风病患者对65-kDa抗原的反应性之间存在显著差异,并且人类对65-kDa抗原的血清反应性表明细菌载量高度升高。